Valneva Lingelbach News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The next generation Covid-19 vaccines seeking a slice of the market
A new group of vaccine makers is hoping to challenge the Covid-19 shots that are already household names, sharpening competition in what is set to be the first ever jab market to encompass the entire global population.
BioNTech/Pfizer and Moderna, the pandemic’s mRNA-based vaccine frontrunners, have already booked billions of dollars in revenue, which they are using to boost production, sign new contracts and entrench their positions. Likewise, Oxford/AstraZeneca and Johnson & Johnson have been rolling out their cheaper and easier to transport shots for months, while Chinese and Russian-made vaccines dominate in several markets. ....

United Kingdom , South Africa , United States , City Of , Ian Jones , Albert Bourla , Clay Heskett , John Grabenstein , Karen Ducey Getty , David Paul Morris Bloomberg , Pierre Kemula , Thomas Lingelbach , Greg Glenn , Oxford Astrazeneca , Olga Smolentseva , Curevac Kemula , Valneva Lingelbach , Walid Gellad , Sean Tucker , University College London , Garnier Co , La Times , University Of Reading , University Of Pittsburgh , Patrick Soon Shiong , California Based Immunitybio ,